Fidelity Investments’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40K Buy
29,641
+11,934
+67% +$24K ﹤0.01% 4230
2025
Q4
$46K Buy
17,707
+16,449
+1,308% +$45K ﹤0.01% 4158
2025
Q3
$3.77K Sell
1,258
-1,586
-56% -$5.66K ﹤0.01% 4842
2025
Q2
$11.4K Buy
2,844
+1,164
+69% +$4.29K ﹤0.01% 4493
2025
Q1
$5.59K Buy
1,680
+1,385
+469% +$6.61K ﹤0.01% 4669
2024
Q4
$1.82K Sell
295
-296
-50% -$1.72K ﹤0.01% 4834
2024
Q3
$3.3K Buy
591
+502
+564% +$3.35K ﹤0.01% 4704
2024
Q2
$665 Buy
89
+84
+1,680% +$518 ﹤0.01% 4839
2024
Q1
$29 Sell
5
-517
-99% -$2.59K ﹤0.01% 5116
2023
Q4
$2.58K Sell
522
-35
-6% -$180 ﹤0.01% 4600
2023
Q3
$2.85K Buy
557
+550
+7,857% +$3.24K ﹤0.01% 4455
2023
Q2
$47 Buy
+7
New +$42 ﹤0.01% 5025

Other funds holding BTMD

Fidelity Investments's BTMD Position: Q1 2026 in Review

Fidelity Investments increased its Biote Corp (BTMD) stake by 67% in Q1 2026, buying an estimated $24K and bringing the position to 29,641 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #4230.

Fidelity Investments first reported a position in BTMD in Q2 2023 and has held it in 12 quarters since. The position peaked at $46K in Q4 2025. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • Fidelity Investments held 29,641 shares of Biote Corp worth $40K as of Q1 2026.
  • Fidelity Investments bought 11,934 Biote Corp shares in Q1 2026, an estimated $24K.
  • Biote Corp made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4230 holding.
  • Fidelity Investments first reported a position in Biote Corp in Q2 2023 and has held it in 12 quarters since.
  • Fidelity Investments's Biote Corp position peaked at $46K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.